Advertisement

Robert Balster resigns as Editor-in-Chief of Drug and Alcohol Dependence.

03:37 EDT 20th June 2013 | BioPortfolio

Summary of "Robert Balster resigns as Editor-in-Chief of Drug and Alcohol Dependence."

No Summary Available

Affiliation

Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA 23298-0310, USA.

Journal Details

This article was published in the following journal.

Name: Drug and alcohol dependence
ISSN: 1879-0046
Pages:

Links

Medical and Biotech [MESH] Definitions

Alcoholism

A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)

National Institute On Alcohol Abuse And Alcoholism (u.s.)

Component of the NATIONAL INSTITUTES OF HEALTH. It conducts research focused on improving the treatment and prevention of alcoholism and alcohol-related problems to reduce the health, social, and economic consequences of this disease. NIAAA, NIMH, and NIDA were created as coequal institutes within the Alcohol, Drug Abuse and Mental Health Administration in 1974. It was established within the NATIONAL INSTITUTES OF HEALTH in 1992.

Naltrexone

Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.

National Institute On Drug Abuse (u.s.)

Component of the NATIONAL INSTITUTES OF HEALTH. It supports a comprehensive research portfolio that focuses on the biological, social, behavioral and neuroscientific bases of drug abuse on the body and brain as well as its causes, prevention, and treatment. NIDA, NIAAA, and NIMH were created as coequal institutes within the Alcohol, Drug Abuse and Mental Health Administration in 1974. It was established within the NATIONAL INSTITUTES OF HEALTH in 1992.

Morphine Dependence

Strong dependence, both physiological and emotional, upon morphine.

Clinical Trials [ 1937 Associated Clinical Trials listed on BioPortfolio]

Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence

The purpose of this study is to see whether naltrexone is safe and useful in preventing alcohol relapse, as well as in decreasing craving for alcohol in people with a diagnosis of alcohol...

Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence - 1

The purpose of this study is to see whether naltrexone is safe and useful in preventing alcohol relapse, as well as in decreasing craving for alcohol in people with a diagnosis of alcohol...

A Placebo-Controlled Trial of Memantine for Alcohol Dependence

The purpose of this study is to obtain a preliminary indication of the safety and effectiveness of oral memantine (40 mg/day) in alcohol dependent patients. This study is a 16-week study...

Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).

Prazosin is an alpha-1 adrenergic receptor antagonist that has been used successfully in the treatment of trauma nightmares and sleep disturbance in combat veterans with PTSD, and alcohol...

Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence

Smoking is often a problem for alcohol dependent individuals. Many people who seek treatment for alcohol dependence are unable to quit smoking. The purpose of this study is to evaluate t...

Search BioPortfolio: